Man Group
FPRX

Man Group’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Man Group’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-296,139
Closed -$11.2M – 2192
2021
Q1 		$11.2M Buy
296,139
+236,210
+394% +$5.89M 0.05% 394
2020
Q4 		$1.02M Sell
59,929
-113,407
-65% -$1.42M ﹤0.01% 1411
2020
Q3 		$815K Sell
173,336
-43,108
-20% -$219K ﹤0.01% 1426
2020
Q2 		$1.32M Sell
216,444
-16,899
-7% -$69.6K 0.01% 1198
2020
Q1 		$530K Sell
233,343
-314,243
-57% -$1.33M ﹤0.01% 1271
2019
Q4 		$2.51M Sell
547,586
-789,261
-59% -$3.13M 0.01% 1269
2019
Q3 		$5.18M Buy
1,336,847
+176,436
+15% +$968K 0.02% 855
2019
Q2 		$7M Buy
1,160,411
+568,017
+96% +$5.43M 0.03% 810
2019
Q1 		$7.94M Buy
592,394
+75,153
+15% +$857K 0.03% 690
2018
Q4 		$4.81M Buy
+517,241
New +$6.15M 0.02% 785
2018
Q3 		– Sell
-6,300
Closed -$100K – 2283
2018
Q2 		$100K Buy
+6,300
New +$110K ﹤0.01% 2069

Man Group's FPRX Position: Q2 2021 in Review

Man Group sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 296,139 shares — an estimated $11.2M sold.

Man Group first reported a position in FPRX in Q2 2018 and held it in 11 quarters. The position peaked at $11.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • Man Group reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • Man Group sold 296,139 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $11.2M.
  • Man Group first reported a position in Five Prime Therapeutics, Inc. in Q2 2018 and held it in 11 quarters.
  • Man Group's Five Prime Therapeutics, Inc. position peaked at $11.2M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Man Group's 13F filing for Q2 2021, filed 16 Aug 2021.